Hirotaka Miyashita

Hirotaka Miyashita

Icahn School of Medicine at Mount Sinai - New York / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4684694
person_outline Hirotaka Miyashita's MOST POPULAR ARTICLES
1-) Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York CityH Miyashita, T Mikami, N Chopra, T Yamada, S Chernyavsky, D Rizk, ...Annals of Oncology 31 (8), 1088-1089, 20203782020
2-) Risk factors for mortality in patients with COVID-19 in New York CityT Mikami, H Miyashita, T Yamada, M Harrington, D Steinberg, A Dunn, ...Journal of general internal medicine 36 (1), 17-26, 20212442021
3-) Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysisT Yamada, M Wakabayashi, T Yamaji, N Chopra, T Mikami, H Miyashita, ...Clinica chimica acta 509, 235-243, 20201262020
4-) Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic …T Yamada, M Wakabayashi, A Bhalla, N Chopra, H Miyashita, T Mikami, ...Cardiovascular diabetology 20, 1-13, 20211252021
5-) Patients with chronic kidney disease have a poorer prognosis of coronavirus disease 2019 (COVID-19): an experience in New York CityT Yamada, T Mikami, N Chopra, H Miyashita, S Chernyavsky, S MiyashitaInternational Urology and Nephrology 52, 1405-1406, 2020592020